How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Rheinmetall AG | €1,850.5 | €1,650.0 |
| DroneShield Ltd | €2.44 | €2.95 |
| NVIDIA Corp. | €153.42 | €192.00 |
| Security | Price | Target price |
|---|---|---|
| T.Rowe Price Group Inc. | €90.00 | €81.62 |
| Dollar Tree Inc. | €111.38 | €108.76 |
| Arbor Realty Trust Inc. | €6.83 | €6.83 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Corvus Pharmaceuticals Inc | Wolf_of_WS | 149.37% |
| B Corvus Pharmaceuticals Inc | Lokrim | 30.74% |
| B Corvus Pharmaceuticals Inc | HC Wainwright | 29.78% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Diginex Ltd. | Lokrim | -41.48% |
| S Fintechwerx Intl Software Svcs | WinLong0 | -28.63% |
| S Diginex Ltd. | kostojunior | -26.96% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Gold By Gold
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Gold Fields Ltd
WKN: 856777 / Name: Gold Fields / Stock / Metals & Mining / Mid Cap /
Pros
Cons
Uranium Energy Corp
WKN: A0JDRR / Name: Uranium Energy / Stock / Uranium / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Intel Corp. | €45.52 | 9.790% |
| Western Digital Corp. | €203.30 | 6.830% |
| Advance Auto Parts Inc. | €37.59 | 6.650% |
| Citizens Financial | €54.02 | 5.960% |
| Advanced Micro Devices Inc. | €209.65 | 5.940% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Kraft Heinz Co | €19.14 | -5.620% |
| Netflix Inc. | €70.91 | -4.980% |
| Oracle Corp. | €146.08 | -4.870% |
| SBA Communications Corp. | €158.60 | -4.790% |
| Fidelity National Information Services Inc. | €51.25 | -3.850% |
Courses
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
sharewise Introduction
Predictions
Top News
D.R. Horton Stock Tests Support Following Earnings Report
Shares of homebuilder D.R. Horton Inc. (NYSE: DHI) are down about 1% in mid-day trading after the company reported its earnings for the first quarter of its 2026 fiscal year. This came despite
Riot Platforms: A $311M AMD Deal Changes the HPC Game
In mid-January, the financial markets witnessed a notable anomaly. While Bitcoin's ($BTC) price faced significant downward pressure, dropping toward $91,000 due to rising geopolitical tensions
Tesla Bulls vs. Bears Are Getting Loud Ahead of Earnings
Shares of Tesla Inc (NASDAQ: TSLA) are trading around $425 as we head into next week’s earnings report, down roughly 15% from the all-time high set in December.
That pullback has been
Defense Spending Is Rising—Here Are 3 Stocks Built for Turbulent Times
We’re only three weeks into 2026, but it already feels like Billy Joel can add another verse to We Didn’t Start the Fire:
Ukraine/Russia tensions boil,
U.S. wants Caracas oil.
Massive protests
3M Earnings: Fundamentals and Capital Returns to Drive Highs in 2026
3M’s (NYSE: MMM) Q4 2025 results and 2026 guidance update failed to trigger a rally; however, they align with a long-term outlook for quality and capital returns that has this market on track to
CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February
Capricor Therapeutics CAPR recently provided a regulatory update on its Biologics License Application (BLA) for Deramiocel, following recent interactions with the FDA. After reviewing topline data
ImmunityBio Stock Soars on FDA Talks for Anktiva sBLA Resubmission
Shares of ImmunityBio IBRX surged 17.4% after it announced a recent face-to-face meeting with senior FDA officials to align on the regulatory path forward for Anktiva in an additional indication
Notes on President Trump's Davos Speech
Wednesday, January 21st, 2026President Trump has arrived in Davos, Switzerland this morning, and presently at the podium for the annual World Economic Forum. This is, quite succinctly, the main even
Can Vertiv's International Expansion Drive More Upside in the Stock?
Vertiv VRT is benefiting from strong international demand for data center infrastructure, driven by the global acceleration of digital transformation and AI adoption. The company reported a robust
Offshore Choices Look Different When You Know What to Check
News
Can B&G Foods' Margin Improvement Hold Amid Soft Demand?
B&G Foods, Inc.’s BGS third-quarter fiscal 2025 results reflect a difficult operating backdrop. Net sales declined 4.7% year over year to $439.3 million, while base business net sales, excluding
FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate
Eli Lilly and Company LLY announced that the FDA has granted a Breakthrough Therapy designation to its novel folate receptor alpha (FRα) antibody-drug conjugate (ADC), sofetabart mipitecan
SIFCO Plunges 14.3% in the Past Three Months: How to Play the Stock?
SIFCO Industries, Inc.'s SIF investors have been experiencing some short-term losses from the stock of late. Shares of the Cleveland, OH-based manufacturer of forgings, sub-assemblies and machined
J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales
Johnson & Johnson’s JNJ fourth-quarter 2025 earnings came in at $2.46 per share, which beat the Zacks Consensus Estimate of $2.43. Earnings rose 20.6% from the year-ago period.
Adjusted earnings
Precious Metal ETF (DBP) Hits New 52-Week High
Invesco DB Precious Metals ETF DBP is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 88.86% from its 52-week low price of $62.84 per share.
Reasons Why You Should Retain Fiserv Stock in Your Portfolio
Fiserv, Inc.’s FISV growth is fueled by the rising adoption of Software-as-a-Service (SaaS) and payment solutions by business houses. Its new acquisitions and AI innovations aid it in gaining access
Are Options Traders Betting on a Big Move in Caleres Stock?
Investors in Caleres, Inc. CAL need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 20, 2026 $30 Call had some of the highest implied
HWC Q4 Earnings Beat Estimates on Fee Income & NII, Shares Dip
Hancock Whitney Corp.’s HWC fourth-quarter 2025 earnings per share of $1.49 beat the Zacks Consensus Estimate by a penny. Further, the bottom line rose 6.4% from the prior year quarter.Results
Contest
Still running
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.